Patient navigation support for breast cancer patients
The Journey of Women With Breast Cancer in Mozambique: What is the Best Path? A Prospective Cohort With Patient Navigation as an Intervention to Reduce Treatment Disparities
This study is testing whether having a patient navigator can help women with breast cancer start treatment faster and improve their chances of survival.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | AC Camargo Cancer Center Academic / other |
| Locations | 1 site (Maputo) |
| Trial ID | NCT06257888 on ClinicalTrials.gov |
What this trial studies
This observational study aims to implement a patient navigation system at Hospital Central de Maputo to enhance oncological outcomes for breast cancer patients. The study will track a cohort of female patients undergoing treatment, collecting data on the time from symptom onset to treatment initiation and overall survival rates. The patient navigator will provide continuous support from admission until treatment begins, with the goal of reducing delays in care. The study will also compare outcomes with historical data to assess the effectiveness of the navigation intervention.
Who should consider this trial
Good fit: Ideal candidates are females aged 18 and older who are set to undergo breast cancer treatment at Hospital Central de Maputo.
Not a fit: Patients with a history of other malignancies or those who have previously received breast cancer treatment elsewhere may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the speed and effectiveness of breast cancer treatment for patients.
How similar studies have performed: While the concept of patient navigation is established, this specific implementation in Mozambique is novel and has not been extensively tested in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * female * 18 years and older * will undergo breast cancer treatment at HCM * consent to participate Exclusion Criteria: * male * less than18 years of age * history of other previous malignancies (including breast cancer) * history of breast cancer treatment initiated elsewhere * lack of consent to participate
Where this trial is running
Maputo
- Hospital Central de Maputo — Maputo, Mozambique (Recruiting)
Study contacts
- Principal investigator: renato cagnacci neto, MD, MSc — AC Camargo Cancer Center
- Study coordinator: renato cagnacci neto, MD, MSc
- Email: renato.neto@accamargo.org.br
- Phone: +55 1121895000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.